Caricamento...

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer

Detection of BRAF(V600E) is useful for making diagnosis and risk stratification of papillary thyroid carcinoma (PTC). Molecular testing, however, is not always available for routine clinical use. To assess the clinical utility and reliability of VE1 immunohistochemistry (IHC) for detecting BRAF(V600...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Choden, Sonam, Keelawat, Somboon, Jung, Chan Kwon, Bychkov, Andrey
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7139976/
https://ncbi.nlm.nih.gov/pubmed/32150939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12030596
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !